Saroglitazar
| CAS No. | 495399-09-2 |
|---|---|
| MDL No. | MFCD28502034 |
| MF | C25H29NO4S |
| MW | 439.60 |
| InChI Key | MRWFZSLZNUJVQW-DEOSSOPVSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Saroglitazar is a monocarboxylic acid, specifically (2S)-2-ethoxy-3-(p-ethoxyphenyl)propanoic acid, in which one methyl hydrogen of the p-ethoxy substituent is replaced by the nitrogen of 2-methyl-5-[4-(methylthio)phenyl]-1H-pyrrole. It is an agonist at PPAR alpha and gamma subtypes, with predominant PPARalpha activity, and is used in the treatment of type 2 diabetes. It functions as a PPARgamma agonist, hypoglycemic agent, and PPARalpha agonist. It belongs to the classes of pyrroles, monocarboxylic acids, methyl sulfides, and aromatic ethers.
| CAS No. | 495399-09-2 |
|---|---|
| Product Name | Saroglitazar |
Biological Targets
PPARA·PPARG
Associated Conditions
primary biliary cirrhosis·Hepatic steatosis·Disorder of lipid metabolism·cirrhosis of liver·liver disease·
* The information provided here is compiled from public sources and is for reference only.
